EXELIXIS INC
For the period ended Apr 4, 2025. Filed May 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Apr 4, 2025 · Filed May 13, 2025
EXEL$70.58-1.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Income (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except per share data)
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Revenues: | ||
| Net product revenues | $513,283 | $378,523 |
| Collaboration revenues | 42,164 | 46,703 |
| Total revenues | 555,447 | 425,226 |
| Operating expenses: | ||
| Cost of goods sold | 19,172 | 21,256 |
| Research and development | 212,233 | 227,689 |
| Selling, general and administrative | 137,183 | 113,984 |
| Restructuring | — | 32,835 |
| Total operating expenses | 368,588 | 395,764 |
| Income from operations | 186,859 | 29,462 |
| Interest income | 19,076 | 19,894 |
| Other expenses, net | (245) | (89) |
| Income before income taxes | 205,690 | 49,267 |
| Provision for income taxes | 46,074 | 11,950 |
| Net income | $159,616 | $37,317 |
| Net income per share: | ||
| Basic | $0.57 | $0.12 |
| Diluted | $0.55 | $0.12 |
| Weighted-average common shares outstanding: | ||
| Basic | 278,804 | 300,757 |
| Diluted | 288,177 | 305,530 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.